ArticleTherapeutic advances in endocrinology and metabolism2026
Efficacy and safety of pralsetinib in multiple endocrine neoplasia type 2-associated pheochromocytoma: a case report.
Shiwei Chen et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.